CD274 and non-small cell lung carcinoma: To address the issue, we investigate association with clinicopathologic characteristics and the prognostic value of PD-L1 expression measured by a commercial 22C3-PD-L1 immunohistochemistry diagnostic assay with a Dako platform in patients with surgically resectable NSCLC.